Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
AIDS Research and Therapy is Scopus-indexed (Q3, CiteScore 3.8), WoS SCIE, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 1742-6405Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 141 / 278 | 49th | Q3 |
| Virology | 46 / 86 | 47th | Q3 |
| Molecular Medicine | 126 / 179 | 29th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q3, CiteScore 3.8.
AIDS Research and Therapy is Q3 in Pharmacology (medical) (rank 141 of 278), Q3 in Virology (rank 46 of 86) and Q3 in Molecular Medicine (rank 126 of 179), by CiteScore 2025.
AIDS Research and Therapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.8, which places it in quartile Q3 at the 49th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.934, quartile Q2, with an H-index of 54.
The publisher lists an article processing charge of about US$2,990 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
AIDS Research and Therapy is published by BioMed Central Ltd. Its ISSN is 1742-6405.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
AIDS Research and Therapy has an h-index of 68 and a 2-year mean of 2.29 citations per paper (OpenAlex). Its Scopus CiteScore is 3.8, quartile Q3. On 2-year citations it ranks #114 of 271 Scopus journals in Pharmacology (medical).
AIDS Research and Therapy published 141 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (24.6%), United States (16.8%) and Uganda (11.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (1.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.